FR2757862B1 - Peptides antigeniques reagissant avec les anticorps anti-ovaire - Google Patents

Peptides antigeniques reagissant avec les anticorps anti-ovaire

Info

Publication number
FR2757862B1
FR2757862B1 FR9616385A FR9616385A FR2757862B1 FR 2757862 B1 FR2757862 B1 FR 2757862B1 FR 9616385 A FR9616385 A FR 9616385A FR 9616385 A FR9616385 A FR 9616385A FR 2757862 B1 FR2757862 B1 FR 2757862B1
Authority
FR
France
Prior art keywords
antigenic peptides
peptides reacting
ovary
antibodies
ovary antibodies
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
FR9616385A
Other languages
English (en)
Other versions
FR2757862A1 (fr
Inventor
Reynaud Colette Jolivet
Gilbert Faure
Pascal Dalbon
Michel Jolivet
Marie Christine Bene
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Biomerieux SA
Original Assignee
Biomerieux SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to FR9616385A priority Critical patent/FR2757862B1/fr
Application filed by Biomerieux SA filed Critical Biomerieux SA
Priority to US09/331,872 priority patent/US6602853B1/en
Priority to EP97947825A priority patent/EP0968229A1/fr
Priority to CA002276490A priority patent/CA2276490A1/fr
Priority to AU54060/98A priority patent/AU5406098A/en
Priority to PCT/IB1997/001611 priority patent/WO1998029450A1/fr
Publication of FR2757862A1 publication Critical patent/FR2757862A1/fr
Application granted granted Critical
Publication of FR2757862B1 publication Critical patent/FR2757862B1/fr
Priority to US10/461,493 priority patent/US20030199452A1/en
Priority to US11/142,327 priority patent/US20050260200A1/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/59—Follicle-stimulating hormone [FSH]; Chorionic gonadotropins, e.g.hCG [human chorionic gonadotropin]; Luteinising hormone [LH]; Thyroid-stimulating hormone [TSH]
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/689—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to pregnancy or the gonads
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/36—Gynecology or obstetrics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Urology & Nephrology (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Hematology (AREA)
  • Reproductive Health (AREA)
  • Endocrinology (AREA)
  • Biomedical Technology (AREA)
  • Pregnancy & Childbirth (AREA)
  • Zoology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • Toxicology (AREA)
  • Microbiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Food Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Peptides Or Proteins (AREA)
FR9616385A 1996-12-31 1996-12-31 Peptides antigeniques reagissant avec les anticorps anti-ovaire Expired - Fee Related FR2757862B1 (fr)

Priority Applications (8)

Application Number Priority Date Filing Date Title
FR9616385A FR2757862B1 (fr) 1996-12-31 1996-12-31 Peptides antigeniques reagissant avec les anticorps anti-ovaire
EP97947825A EP0968229A1 (fr) 1996-12-31 1997-12-31 Peptides antigeniques reagissant avec les anticorps anti-ovaire
CA002276490A CA2276490A1 (fr) 1996-12-31 1997-12-31 Peptides antigeniques reagissant avec les anticorps anti-ovaire
AU54060/98A AU5406098A (en) 1996-12-31 1997-12-31 Antigenic peptides reacting with anti-ovary antibodies
US09/331,872 US6602853B1 (en) 1996-12-31 1997-12-31 Antigenic peptides reacting with anti-ovary antibodies
PCT/IB1997/001611 WO1998029450A1 (fr) 1996-12-31 1997-12-31 Peptides antigeniques reagissant avec les anticorps anti-ovaire
US10/461,493 US20030199452A1 (en) 1996-12-31 2003-06-16 Antigenic peptides reacting with anti-ovary antibodies
US11/142,327 US20050260200A1 (en) 1996-12-31 2005-06-02 Antigenic peptides reacting with anti-ovary antibodies

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9616385A FR2757862B1 (fr) 1996-12-31 1996-12-31 Peptides antigeniques reagissant avec les anticorps anti-ovaire

Publications (2)

Publication Number Publication Date
FR2757862A1 FR2757862A1 (fr) 1998-07-03
FR2757862B1 true FR2757862B1 (fr) 1999-01-29

Family

ID=9499441

Family Applications (1)

Application Number Title Priority Date Filing Date
FR9616385A Expired - Fee Related FR2757862B1 (fr) 1996-12-31 1996-12-31 Peptides antigeniques reagissant avec les anticorps anti-ovaire

Country Status (6)

Country Link
US (3) US6602853B1 (fr)
EP (1) EP0968229A1 (fr)
AU (1) AU5406098A (fr)
CA (1) CA2276490A1 (fr)
FR (1) FR2757862B1 (fr)
WO (1) WO1998029450A1 (fr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7321570B2 (en) * 2004-02-03 2008-01-22 Motorola, Inc. Method and apparatus for dynamic power allocation to a multimedia broadcast/multicast service

Also Published As

Publication number Publication date
EP0968229A1 (fr) 2000-01-05
US20050260200A1 (en) 2005-11-24
WO1998029450A1 (fr) 1998-07-09
FR2757862A1 (fr) 1998-07-03
US20030199452A1 (en) 2003-10-23
CA2276490A1 (fr) 1998-07-09
US6602853B1 (en) 2003-08-05
AU5406098A (en) 1998-07-31

Similar Documents

Publication Publication Date Title
NO985464D0 (no) Konsentrert antistoffpreparat
CY2005008I1 (el) Αντισωματα αντι - vegf
IS5375A (is) KAY-nýstárlegt ónæmisprótín
NO983141L (no) Antigene peptider
DE69839603D1 (de) Zierenden proteins
DK0941344T3 (da) Humaniserede anti-CD11a-antistoffer
ATE218883T1 (de) Verbesserte interferon-polymer konjugate
DE69735926D1 (de) Interleukin-18 Rezeptorproteine
LV11630A (lv) T sunu antigena receptora V apgabala pilna garuma olbaltumvielas
BR9508433A (pt) Peptídeos
IT1303546B1 (it) Cerniera lampo.
NO985989L (no) Forbedret dunnasje-luftpose
NO981454L (no) Anti-FAS-antistoffer
DK0863991T3 (da) Antigeniske præparater
FI943418A (fi) Synteettiset peptidit vihurirokkorokotetta varten
EP0888126A4 (fr) Vaccin a base d'un anticorps antiidiotype
NO974924D0 (no) Modifiserte polypeptider med öket immunogenisitet
FR2757862B1 (fr) Peptides antigeniques reagissant avec les anticorps anti-ovaire
NO975938D0 (no) Anti-fedme proteiner
PT950063E (pt) Construcoes peptidicas multirramificadas
GB9718911D0 (en) Monoclonal antibodies
DE69615850D1 (de) G-protein-gekoppelter rezeptor hnfd578
NO970872D0 (no) Farseformer
BR9709080A (pt) Anticorpo monoclonal anti-MP52 humano
DK1017798T3 (da) Lunasinpeptider

Legal Events

Date Code Title Description
ST Notification of lapse

Effective date: 20081020